Search:
Home
|
Register
or
Login
|
Contact Us
****JavaScript based drop down DHTML menu generated by NavStudio. (OpenCube Inc. - http://www.opencube.com)****
Educational Resources Home
DMC Education Center
Literature Library
Slide Library
Multimedia Library
Diagnostic Tools and Techniques
Conference Reports
Upcoming Scientific Events
American Academy of Ophthalmology 2006
Saturday, November 11
Diabetic Retinopathy in 2006: What a Difference a Year Makes!
What's Happening in Diabetes This Year?
The Science Behind the Disease: Unraveling the Molecular Biology of Diabetic Retinopathy
From Science to Clinic: Recent and Ongoing Clinical Trials
Sunday, November 12
Advances in Diabetic Retinopathy
Vein Occlusions
Advances in Surgical Treatments
Advances in Diagnostic Imaging
Evaluation of an Intravitreous Dexamethasone Drug Delivery System in Patients with Persistent Diabetic Macular Edema
Pegaptanib in Diabetic Retinopathy: Improvements in Diabetic Macular Edema, Retinal Neovascularization, and Diabetic Retinopathy Severity
Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema: Results of a Multicenter Collaborative Study Group
Bevacizumab vs Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema: Six-Week Results of a Clinical Trial
VEGF Small Interfering RNA (Cand5) for the Treatment of Diabetic Macular Edema
Vitrectomy for Nontractional Diffuse Diabetic Macular Edema: Study Design and Preliminary Results of the VIDE Study
Intravitreal Bevacizumab (Avastin) in the Surgical Treatment of Proliferative Diabetic Retinopathy
Safety of an Intravitreal Injection of Bevacizumab (Avastin): Results of a Multicenter Trial
Effect of Ruboxistaurin on Reversibility of Vision Loss in Patients with Nonproliferative Diabetic Retinopathy
Incidence of Endophthalmitis For 25-gauge Vitrectomy
Monday, November 13
Rationale for Pharmacologic Treatment of Retinal Vascular Disease
Pharmacologic Manipulation of the Vitreous Cavity
Anti-VEGF Therapy for Diabetic Macular Edema
Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy and Diabetic Macular Edema
Surgical Management of Diabetic Traction Retinal Detachments
Avastin for Retinal Vascular Diseases
Economic Impact of Therapy for Retinal Vascular Disease on Physicians and Society
Basic Science of Diabetic Macular Edema
Blood-Retinal Barrier Composition
Diabetic Retinopathy Etiology—Theories
Biochemistry of Diabetic Macular Edema
Diagnosis of Diabetic Macular Edema and the Roles of OCT and Fluorescein Angiography in 2006
Treatment Considerations for Diabetic Macular Edema
Conventional Treatments and Metabolic and Systemic Issues Influencing Diabetic Retinopathy
Corticosteroids and Diabetic Retinopathy
Future Treatments for Diabetic Macular Edema
Tuesday, November 14
Ocular Examination
Medical Treatment of Diabetes—Effects on Retina
Diabetic Macular Edema
Proliferative Diabetic Retinopathy
Panel Discussion
Diabetic Retinopathy
Hypertensive Retinopathy
Systemic Diseases and Cystoid Macular Edema
Retinal Manifestations of Drug Toxicity
About Us
|
Terms of Use
|
Privacy Statement
|
Disclaimer